Literature DB >> 24804620

Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro.

Zhi-Zhong Zheng1, Yan-Lin Ming1, Liang-Hua Chen1, Guo-Hua Zheng1, Shao-Song Liu1, Qing-Xi Chen2.   

Abstract

An intestinal bacterial metabolite of ginseng protopanaxadiol saponin, 20-O-(β-D-glucopyranosyl)-20(S)-protopanaxadiol (compound K), has been reported to induce apoptosis in a variety of cancer cells. However, the precise mechanisms induced by compound K in human hepatocellular carcinoma (HCC) cells remain unclear. In order to examine possible apoptotic mechanisms, we investigated the anticancer effect of compound K in MHCC97-H. MTT assay showed that compound K inhibited the proliferation of MHCC97-H cells with a relatively low toxicity in normal hepatoma cells. Cell cycle progression and cell staining showed an increase in apoptotic sub-G1 fraction. Treatment of MHCC97-H with compound K also induced a reduction in mitochondrial membrane potential (Δψm) and DNA damage. Further study showed that compound K upregulated Fas, FasL, Bax/Bcl-2 ratio and downregulated pro-caspase-9, pro-caspase-3 in a dose-dependent manner, and it also inhibited Akt phosphorylation. These results suggest that compound K significantly inhibits cell proliferation and induces apoptosis in MHCC97-H cells through Fas- and mitochondria-mediated caspase-dependent pathways in human HCC cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24804620     DOI: 10.3892/or.2014.3171

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells.

Authors:  Yang Li; Tong Zhou; Chengyuan Ma; Weiwei Song; Jian Zhang; Zhenxiang Yu
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.

Authors:  R M Helliwell; C O ShioukHuey; K Dhuna; J C Molero; J-M Ye; C C Xue; L Stokes
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 3.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

4.  Compound K Attenuates the Development of Atherosclerosis in ApoE(-/-) Mice via LXRα Activation.

Authors:  Li Zhou; Yu Zheng; Zhuoying Li; Lingxia Bao; Yin Dou; Yuan Tang; Jianxiang Zhang; Jianzhi Zhou; Ya Liu; Yi Jia; Xiaohui Li
Journal:  Int J Mol Sci       Date:  2016-07-08       Impact factor: 5.923

5.  Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.

Authors:  Lei Yang; Zhenghai Zhang; Jian Hou; Xin Jin; Zhongcheng Ke; Dan Liu; Mei Du; Xiaobing Jia; Huixia Lv
Journal:  Int J Nanomedicine       Date:  2017-10-17

6.  The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells.

Authors:  Sanghun Lee; Min Cheol Kwon; Jun-Pil Jang; Jae Kyung Sohng; Hye Jin Jung
Journal:  Int J Oncol       Date:  2017-06-23       Impact factor: 5.650

Review 7.  Ginseng for Liver Injury: Friend or Foe?

Authors:  Tae-Woo Kim
Journal:  Medicines (Basel)       Date:  2016-12-17

8.  Synthesis and Biological Evaluation of Ginsenoside Compound K Derivatives as a Novel Class of LXRα Activator.

Authors:  Yan Huang; Hongmei Liu; Yingxian Zhang; Jin Li; Chenping Wang; Li Zhou; Yi Jia; Xiaohui Li
Journal:  Molecules       Date:  2017-07-24       Impact factor: 4.411

9.  General and Genetic Toxicology of Enzyme-Treated Ginseng Extract: Toxicology of Ginseng Rh2.

Authors:  Mi-Kyung Jeong; Chong-Kwan Cho; Hwa-Seung Yoo
Journal:  J Pharmacopuncture       Date:  2016-09

10.  Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma.

Authors:  Cheng Gong; Jing Fang; Guang Li; Han-Han Liu; Zhi-Su Liu
Journal:  Oncotarget       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.